RSS

CDMO

Shabbir Mostafa, global key account director for Recipharm Inhalation Solutions, looks at the techniques to reduce time to market during inhalation drug development and manufacturing. Read more

Opinion

Global contract development and manufacturing organisation (CDMO) Vetter has reached an ‘environmental milestone’ by supplying all of its German sites with CO2 natural energy. Read more

News

In this interview, we at EPM magazine speak with Staffan Widengren, director of corporate projects at Recipharm on the difficulties CDMOs are facing leading up to the European Falsified Medicines Directive (EU FMD) deadline in February 2019. Read more

Opinion

Innovative biotechnology company, ADC Biotechnology, has secured £1.14 million in funding from Downing LLP to assist the company in its US expansion and aid in the development of an advanced bioconjugation method. Read more

News

Global active pharmaceutical ingredient (API) developer and manufacturer, Sterling Pharma Solutions, has experienced growth within the Japanese market and as such is now working with numerous clients in the region. Read more

News

International contract development and manufacturing organisation (CDMO), Hovione has announced the enrolment of the first patient in the Phase II clinical trial of its topical minocycline (HY01) in moderate to severe papulopustular rosacea patients. Read more

News

CPhI Worldwide has revealed the finding from part i of its fifth edition of the CPhI Annual Report, which show the trend towards the integration of pharmaceutical outsourcing continues but the rate of change remains unclear. Read more

Analysis

Piramal Pharma Solutions (PPS), a contract development and manufacturing organisation (CDMO), is investing $55 million across its sites in North America and Asia to expand its API manufacturing capabilities and capacities. Read more

News

Vantage Consulting Group, a manufacturing automation expert, has joined the Pharma & Biopharma Outsourcing Association (PBOA). It will be the first systems integrator to join the association. Read more

News

Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long-term agreement with Sato Pharmaceuticals for the commercial manufacture and delivery of Emla Patch to Japanese market. Read more

News

CDMO Recipharm has partnered with firms Marchesini, SEA Vision and TraceLink to develop new serialisation services. Read more

Technology

Global CDMO Aesica Pharmaceuticals has announced a modular packaging system designed to comply with all the varying serialisation regulations across the globe - including China and Korea Read more

News

Norwich Pharma Services is a recognised leader in full-service contract pharmaceutical development and manufacturing. Read more

News

Vetter is a leading contract development and manufacturing organization that specializes in the aseptic filling of syringes, cartridges and vials. Read more

News

Aesica, the global CDMO, provides finished dose and API services to leading pharmaceutical and emerging biotechnology organisations. Read more

News

The company can now offer liquid filling into capsules, complementing its existing powder and semi-solid capsule filling capability. Read more

Sales at Aesica have increased from £25 million in 2004 to close to £200 million in 2013. Read more

The contract development and manufacturing organisation, Recipharm, has signed an agreement to acquire Milan-based Corvette Pharmaceutical Services Group from Italian private equity Group LBO Italia Investimenti. Read more

Encube Ethicals, a pharmaceutical CDMO focussing on dermatology and semisolid manufacturing from its facility located in Goa, India, has been proudly associated with CPhi Worldwide/ICSE for the past three years. Read more

News

CDMO Almac has announced the successful inspection of its new US commercial packaging operations located in Audubon, Pennsylvania, US, by the FDA. The inspection took place on 9–10 January 2013 and the regulatory body concluded that... Read more

Technology